Children Can Remain HIV-Free After Pause in Antiretroviral Therapy
By Elana Gotkine HealthDay Reporter
WEDNESDAY, March 13, 2024 -- Very early treatment of in utero HIV-1 can result in antiretroviral therapy (ART)-free remission for ≥48 weeks, according to a study presented at the annual Conference on Retroviruses and Opportunistic Infections, held from March 3 to 6 in Denver.
Deborah Persaud, M.D., from the Johns Hopkins University School of Medicine in Baltimore, and colleagues describe six children who received very early nevirapine- or protease inhibitor-based ART (initiation within 48 hours of birth) and underwent analytical treatment interruption (ATI) to assess for remission.
The researchers found that the children underwent ATI at a median of 5.5 years old. Four achieved study-defined remission (absence of replicating virus for ≥48 weeks off ART) one through 80 weeks of ATI, at which point viral rebound occurred. The other three remained in remission for 48, 52, and 64 weeks, respectively. Viral rebound occurred three and eight weeks after ATI in two children. Two children with rebound at 80 and eight weeks experienced mild acute retroviral syndrome; during or following ATI, there were no other clinical or immunological events of concern reported. The children with rebound at three or eight weeks had HIV RNA below the limit of detection at eight and 20 weeks after resumption of ART. Two weeks after resuming ART, the child with rebound at 80 weeks had HIV-1 RNA 724 cp/mL.
"These results are groundbreaking for HIV remission and cure research, and they also point to the necessity of immediate neonatal testing and treatment initiation in health care settings for all infants potentially exposed to HIV in utero," Persaud said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
BMI Cutoff of 30 for Obesity May Be Too High for Middle-Aged, Older Adults
FRIDAY, May 31, 2024 -- The optimal body mass index (BMI) cutoff point appears to be 27 kg/m2 for detecting obesity in middle-aged and older adults, according to a study presented...
Emergency Inguinal Hernia Surgery Rates Increased With Lower Country Income
FRIDAY, May 31, 2024 -- For patients undergoing inguinal hernia surgery, emergency surgery rates increase from high- to low-income countries, according to a study published online...
Maternal Serum Alpha-Fetoprotein Levels Higher in Black Than White Women
FRIDAY, May 31, 2024 -- Maternal serum alpha-fetoprotein (AFP) levels are higher in Black than White pregnant women, supporting the use of accounting for these differences in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.